Clinical characteristics and medical management of Iranian patients with ankylosing spondylitis

References

• Sengupta R, Stone MA. The assessment of ankylosing spondylitis in clinical practice. Nat Clin Pract Rheumatol. 2007;3(9):496–503.
   PubMedGoogle Scholar
• Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570): 1379–90.
   PubMed Web of Science ®Google Scholar
• Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61(Suppl 3):iii8–18.
   Google Scholar
• Nicknam MH, Mahmoudi M, Amirzargar AA, Ganjalikhani Hakemi M, Khosravi F, Jamshidi AR, et al. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis. Iran J Allergy Asthma Immunol. 2008;7(1):19–24.
   PubMed Web of Science ®Google Scholar
• Fouladi S, Adib M, Salehi M, Karimzadeh H, Bakhshiani Z, Ostadi V. Distribution of HLA-B*27 alleles in patients with ankylosing spondylitis in Iran. Iran J Immunol. 2009;6(1):49–54.
   PubMed Web of Science ®Google Scholar
• Nazarinia MA, Ghaffarpasand F, Heiran HR, Habibagahi Z. Pattern of ankylosing spondylitis in an Iranian population of 98 patients. Mod Rheumatol. 2009;19(3):309–15.
   PubMed Web of Science ®Google Scholar
• Ankylosing Spondylitis Society in Iran. Ankylosing Spondylitis International Federation (ASIF). Available from: http://www.asif.rheumanet.org/iran.htm [accessed 24 Dec 2012].
   Google Scholar
• van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–8.
   PubMed Web of Science ®Google Scholar
• Feldtkeller E, Erlendsson J. Definition of disease duration in ankylosing spondylitis. Rheumatol Int. 2008;28(7):693–6.
   PubMed Web of Science ®Google Scholar
• van der Heijde D, van der Linden S, Bellamy N, Calin A, Dougados M, Khan MA. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol. 1999;26(4):945–7.
   PubMed Web of Science ®Google Scholar
• Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286–91.
   PubMed Web of Science ®Google Scholar
• Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281–5.
   PubMed Web of Science ®Google Scholar
• Jones SD, Porter J, Garrett SL, Kennedy LG, Whitelock H, Calin A. A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI). J Rheumatol. 1995;22(8):1609.
   PubMed Web of Science ®Google Scholar
• Bidad K, Fallahi S, Mahmoudi M, Jamshidi A, Farhadi E, Meysamie A, Nicknam MH. Evaluation of the Iranian versions of the bath ankylosing spondylitis disease activity index (BASDAI), the bath ankylosing spondylitis functional index (BASFI) and the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Rheumatol Int. 2012;32(11):3613–8.
   PubMed Web of Science ®Google Scholar
• Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis. 2003;62(1):20–6.
   PubMed Web of Science ®Google Scholar
• Feldtkeller E. [Age at disease onset and delayed diagnosis of spondyloarthropathies]. Z Rheumatol. 1999;58(1):21–30.
   PubMed Web of Science ®Google Scholar
• Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003;23(2):61–6.
   PubMed Web of Science ®Google Scholar
• Collantes E, Zarco P, Munoz E, Juanola X, Mulero J, Fernandez-Sueiro JL, et al. Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report. Rheumatology (Oxford). 2007;46(8):1309–15.
   PubMed Web of Science ®Google Scholar
• Bodur H, Ataman S, Bugdayci DS, Rezvani A, Nas K, Uzunca K, et al.; Türkiye Romatizma Araştırma ve Savaş Derneği [TRASD] (Turkish League Against Rheumatism) Ankylosing Spondylitis [AS] Study Group. Description of the registry of patients with ankylosing spondylitis in Turkey: TRASD-IP. Rheumatol Int. 2012;32(1):169–76.
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Malaviya AN. Clinical characteristics of patients with ankylosing spondylitis in India. Clin Rheumatol. 2009;28(10): 1199–205.
   PubMed Web of Science ®Google Scholar
• Baek HJ, Shin KC, Lee YJ, Kang SW, Lee EB, Yoo CD, Song YW. Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. Rheumatology (Oxford). 2004;43(12):1526–31.
   PubMed Web of Science ®Google Scholar
• Brophy S, Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol. 2001; 28(10):2283–8.
   PubMed Web of Science ®Google Scholar
• Casals-Sanchez JL, Garcia De Yebenes Prous MJ, Descalzo Gallego MA, Barrio Olmos JM, Carmona Ortells L, Hernandez Garcia C; Grupo de Estudio emAR II. Characteristics of patients with spondyloarthritis followed in rheumatology units in Spain. emAR II study. Reumatol Clin. 2012;8(3):107–13.
   PubMedGoogle Scholar
• Weisman M, Learch TJ, Baraliakos X, Chandran V, Gladman DD, Raychaudhuri SP, et al.; SPARTAN Group. Current controversies in spondyloarthritis: SPARTAN. J Rheumatol. 2010;37(12):2617–23.
   PubMed Web of Science ®Google Scholar
• Skare TL, Bortoluzzo AB, Goncalves CR, Braga da Silva JA, Ximenes AC, Bertolo MB, et al. Ethnic influence in clinical and functional measures of Brazilian patients with spondyloarthritis. J Rheumatol. 2012;39(1):141–7.
   PubMed Web of Science ®Google Scholar
• Reed MD, Dharmage S, Boers A, Martin BJ, Buchanan RR, Schachna L. Ankylosing spondylitis: an Australian experience. Intern Med J. 2008;38(5):321–7.
   PubMed Web of Science ®Google Scholar
• Ozgocmen S, Ardicoglu O, Kamanli A, Kaya A, Durmus B, Yildirim K, et al. Pattern of disease onset, diagnostic delay, and clinical features in juvenile onset and adult onset ankylosing spondylitis. J Rheumatol. 2009;36(12):2830–3.
   PubMed Web of Science ®Google Scholar
• Stone M, Warren RW, Bruckel J, Cooper D, Cortinovis D, Inman RD. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum. 2005–15;53(3):445–51.
   PubMed Web of Science ®Google Scholar
• Rudwaleit M, Hohler T. Cytokine gene polymorphisms relevant for the spondyloarthropathies. Curr Opin Rheumatol. 2001;13(4): 250–4.
   PubMed Web of Science ®Google Scholar
• Carter JD, Gerard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, et al. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum. 2009;60(5):1311–6.
   PubMed Web of Science ®Google Scholar
• Zeidler H, Rihl M. Time to prove the infective etiology of ankylosing spondylitis and related spondylarthritides: Comment on the article by Carter et al. Arthritis Rheum. 2009;60(11):3519–20;author reply 3520–1.
   PubMed Web of Science ®Google Scholar
• Bittles A. Consanguinity and its relevance to clinical genetics. Clin Genet. 2001;60(2):89–98.
   PubMed Web of Science ®Google Scholar
• Gunal EK, Sarvan FO, Kamali S, Gul A, Inanc M, Carin M, et al. Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey. Joint Bone Spine. 2008;75(3):299–302.
   PubMed Web of Science ®Google Scholar
• Eshed I, Bollow M, McGonagle DG, Tan AL, Althoff CE, Asbach P, Hermann KG, et al. MRI of enthesitis of the appendicular skeleton in spondyloarthritis. Ann Rheum Dis. 2007;66(12):1553–9.
   PubMed Web of Science ®Google Scholar
• El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011;22(6):554–60.
   PubMed Web of Science ®Google Scholar
• Singh JA, Strand V. Health care utilization in patients with spondyloarthropathies. Rheumatology (Oxford). 2009;48(3):272–6.
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9:167.
   PubMed Web of Science ®Google Scholar
• Bremander A, Petersson IF, Bergman S, Englund M. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken). 2011;63(4):550–6.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Rivera S, Hassanhi M, Marquez G, Hernandez R, Villalobos C, Montiel M, et al. HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela. Hum Immunol. 2003;64(7):745–9.
   PubMed Web of Science ®Google Scholar
• Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol. 2001;13(4): 265–72.
   PubMed Web of Science ®Google Scholar
• Lopez-Larrea C, Sujirachato K, Mehra NK, Chiewsilp P, Isarangkura D, Kanga U, et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens. 1995;45(3):169–76.
   PubMedGoogle Scholar
• Lee SH, Choi IA, Lee YA, Park EK, Kim YH, Kim KS, et al. Human leukocyte antigen-B*2705 is the predominant subtype in the Korean population with ankylosing spondylitis, unlike in other Asians. Rheumatol Int. 2008;29(1):43–6.
   PubMed Web of Science ®Google Scholar
• Khan MA. Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol. 2000;12(4):235–8.
   PubMed Web of Science ®Google Scholar
• Oguz FS, Ocal L, Diler AS, Ozkul H, Asicioglu F, Kasapoglu E, et al. HLA B-27 subtypes in Turkish patients with spondyloarthropathy and healthy controls. Dis Markers. 2004;20(6):309–12.
   PubMed Web of Science ®Google Scholar
• Sykes SPM. A history of Persia. London: Macmillan and co., limited; 1921.
   Google Scholar
• van den Berg R, Baraliakos X, Braun J, van der Heijde D. First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Rheumatology (Oxford). 2012;51(8):1388–96.
   PubMed Web of Science ®Google Scholar